Griffiths Graham's Form 4 filing
Barinthus Biotherapeutics plc. (BRNS) · filed Jul 15, 2022
- Accession no.
- 0001104659-22-080206
- Filed
- Jul 15, 2022
- Trade date
- Jun 23-24, 2022
- Filing delay
- 22 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 5 non-derivative transactions and 3 derivative transactions. Open-market sales total $42.24. It was filed 22 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Griffiths GrahamCIK 0001851630 | Officer (Chief Business Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 23, 2022 | Ordinary Shares | MOption exerciseAcquired | +1,931 | $0.00 | $0 | 117,830 | Direct | |
| Jun 23, 2022 | Ordinary Shares | MOption exerciseAcquired | +2,317 | $0.00 | $0 | 120,147 | Direct | |
| Jun 23, 2022 | Ordinary Shares | MOption exerciseAcquired | +3,090 | $0.00 | $0 | 123,237 | Direct | |
| Jun 23, 2022 | Ordinary Shares | SSaleDisposed | −8 | $5.28 | −$42.24 | 123,229 | Direct | |
| Jun 24, 2022 | Ordinary Shares | LLess common codeAcquired | +100 | $5.87 | +$587 | 123,329 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 23, 2022 | Ordinary Shares | MOption exerciseDisposed | −1,931 | $0.00 | $0 | 0 | Direct | |
| Jun 23, 2022 | Ordinary Shares | MOption exerciseDisposed | −2,317 | $0.00 | $0 | 2,317 | Direct | |
| Jun 23, 2022 | Ordinary Shares | MOption exerciseDisposed | −3,090 | $0.00 | $0 | 6,180 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.